Heart NeoplasmsTomography, X-Ray ComputedFatal OutcomeAntineoplastic Combined Chemotherapy ProtocolsChemotherapy, AdjuvantMagnetic Resonance ImagingRadiation DosageRadiation, IonizingRadiation InjuriesDose-Response Relationship, RadiationCombined Modality TherapyRadiation ToleranceRadiationAntineoplastic AgentsRadiation ProtectionCisplatinRadiation MonitoringTreatment OutcomeDoxorubicinCyclophosphamideMass SpectrometryRadiotherapyNeoadjuvant TherapyBreast NeoplasmsDisease-Free SurvivalNeoplasm StagingRadiation OncologySurvival AnalysisEtoposidePrognosisSurvival RateRadiotherapy DosageDrug Administration ScheduleRadiation PneumonitisCosmic RadiationRadiation Injuries, ExperimentalNeoplasm Recurrence, LocalLung NeoplasmsMethotrexateNeoplasmsCarboplatinNeoplasms, Radiation-InducedPaclitaxelRadiotherapy, AdjuvantGamma RaysVinblastineTime FactorsInduction ChemotherapyFollow-Up StudiesBackground RadiationTaxoidsBleomycinDrug Resistance, NeoplasmRadiometryIfosfamideDeoxycytidineAntimetabolites, AntineoplasticBrain NeoplasmsBody Mass IndexOrganoplatinum CompoundsAdenocarcinomaAntineoplastic Agents, AlkylatingRadiation-Sensitizing AgentsCarcinoma, Non-Small-Cell LungUltraviolet RaysRadiation EffectsSalvage TherapyNeoplasm MetastasisHodgkin DiseaseRadiation-Protective AgentsAnthracyclinesProspective StudiesDose FractionationCytarabineOvarian NeoplasmsLymphoma, Non-HodgkinRadiotherapy, ConformalChemotherapy, Cancer, Regional PerfusionTesticular NeoplasmsCell Line, TumorDacarbazineCarcinoma, Squamous CellAntineoplastic Agents, PhytogenicVomitingHead and Neck NeoplasmsTransplantation, AutologousNeutropeniaChemoradiotherapyClinical Trials as TopicNauseaTandem Mass SpectrometrySpectrometry, Mass, Electrospray IonizationCranial IrradiationColorectal NeoplasmsKaplan-Meier EstimateBone NeoplasmsRadiotherapy, Intensity-ModulatedAcute Radiation SyndromeAntibiotics, AntineoplasticLomustine